Home
News
Latest News
People Moves
Business Briefs
Newsletters
Features
Features
Reprints
Surveys
Editorial Calendar
Web Exclusives
Issue Archive
Events
MM&M Awards 2012
txt4pharma
MM&M Virtual Summit
Webcasts
Leadership Exchanges
Whitepapers
Directories
Creative Portfolio
Mobile Guide
Interactive Guide
Pharmaceutical Marketers Directory
MM&M Service Directory
Agency Gallery
Direct Marketing Showcase
Medical Education Review
Sales Force Listings
Jobs
About Us
Subscriber Services
Contact Us
Media Information
Editorial Advisory Board
Drug Info
New Drug Dossier
Drug Database
Subscribe
Order Now
Subscriber Services
Newsletters
RSS
|
Login
|
Register
Med Ed Report Articles
Success seen in fighting CME bias
Marc Iskowitz
March 01, 2012
Progress in keeping commercial bias from industry-based certified CME is at hand, say those who produce and fund it.
Med Ed Report briefs—March 2012
Marc Iskowitz
March 01, 2012
News on FDA, Med-IQ, the American Medical Student Association, Best Practices, the American College of Physicians and CECity
CME quality has slid, docs say: poll
Marc Iskowitz
February 01, 2012
A quarter of physicians in a recent survey cited a decrease in CME quality as commercial support has dropped.
Marquis' big tent vision for Alliance
Marc Iskowitz
February 01, 2012
Damon Marquis wants to make one thing clear: CME is not the only important form of medical education.
Sunshine may be problem for CME
Marc Iskowitz
February 01, 2012
Ppatient advocacy groups and professional medical associations producing CME, though they may not be "covered recipients" under the Sunshine Act, could still be impacted
Med Ed Report briefs
Marc Iskowitz
February 01, 2012
News on Us Healthconnect, Medical Insight, PCI and LLC
Med Ed Report briefs
Marc Iskowitz
January 01, 2012
News on FDA, ProMed Communications, Pfizer, Plannernet, and The Alliance for CME
Pfizer's new take on med-ed funding
Marc Iskowitz
January 01, 2012
Pfizer is changing the way it funds medical education to make smarter use of shrinking funding and enhance the impact of activities, the firm said.
Under new ownership, Pri-Med plans to expand its focus
Marc Iskowitz
January 01, 2012
Pri-Med is under new ownership following M|C Holding's sale of the US assets to closely held Canadian event and media producer Diversified Business Communications.
Stanford works to raise the CME bar
Marc Iskowitz
November 01, 2011
Stanford's new Center for Medical Education Research and Innovation, initially tasked with exploring ways of delivering undergraduate and graduate medical education, could also help Stanford's CME program realize one of its goals.
« Previous
Next »
Video Exclusive
Web Exclusives
Five industry experts advise specialty pharma company on digital strategy
April 20, 2012
Specialty pharma company POZEN assembled a crack team of experts to help shape its digital strategy. Not only did POZEN share with us the text from their contributions, but you can watch exclusive video clips of their valuable perspectives right here.
MM&M Awards 2011 HIghlights
The Best MM&M Awards Ever!
MAHF Ceremony 2012
Photos from the Medical Advertising Hall of Fame Awards ceremony
Most Popular
Most Emailed
Most Recent
Humira on solid ground, analysts say, despite vote on Pfizer hopeful
Goodbye Plavix, hello competition
Sales forces shrank in 2011, but not everywhere
Wolters Kluwer deals health analytics unit to private equity firm
RX-to-OTC proposal gets mixed reviews
No-see docs are know-nothings when it comes to new drug info, study suggests
Pharmas are from Mars, Payers are from Venus
Study: Young Latinas are key decision makers, prefer English
How CDC's hep.-C testing advice benefits drugmakers now
Coach vs. cancer in BMS-backed awareness effort
Harvard urges faculty to ditch journals
Study: Young Latinas are key decision makers, prefer English
Pharma Report 2012: Get Back in Shape
Massachusetts gift ban under attack (again)
Pfizer, Crestor tops for global promotional spend in 2011
Novo Nordisk plans US hiring spree as Q1 sales jump 10%
Med Ed Report: Show Me the Money
No-see docs are know-nothings when it comes to new drug info, study suggests
Wolters Kluwer deals health analytics unit to private equity firm
Humira on solid ground, analysts say, despite vote on Pfizer hopeful
Did FDA's Vytorin warning negatively impact health outcomes?
Roundtable outlines path for publisher, pharma credibility
No-see docs are know-nothings when it comes to new drug info, study suggests
E-prescriptions boost adherence data
How CDC's hep.-C testing advice benefits drugmakers now
PhRMA's Washington wish list
Study: Young Latinas are key decision makers, prefer English
Pharmas are from Mars, Payers are from Venus
Goodbye Plavix, hello competition
Indian conglomerate buys Manhattan Research parent for $635m
Popular Topics
Acquisition
Adherence
App
Celebrity
Clinical Trial
Co-Marketing
Diabetes
Diagnostics
Digital
Direct To Consumer (DTC)
Disease Awareness
Downsize
Education & Awareness
FDA
Government
Guidance
Health Plans
HMOs
Hospitals
Insurers
Law
Marketing Research
Medical Journal
Mobile
Sales Force